Log in to your Inderes Free account to see all free content on this page.

Hansa Biopharma

27.68 SEK

+2.22%

Less than 1K followers

HNSA

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Hansa Biopharma

2019202020212022202320242025
Revenue3.46.133.9154.5134.1171.3222.3
growth-%81.3 %455.6 %356.1 %-13.2 %27.8 %29.7 %
EBITDA-359.7-422.8-547.0-587.1-788.5-637.4-520.7
EBIT-359.7-422.8-547.0-587.1-788.5-637.4-520.7
Profit before taxes-359.6-420.9-548.1-608.4-830.8-803.7-527.0
Net income-360.0-420.9-548.3-609.6-831.7-806.7-529.3
EPS-8.99-10.16-12.33-13.57-15.83-12.84-6.52
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %
Login required

This content is only available for logged in users

Profitability and return on capital

2019202020212022202320242025
EBITDA-%-10,691.7 %-6,933.5 %-1,614.5 %-379.9 %-588.0 %-372.0 %-234.3 %
EBIT-%-10,691.7 %-6,933.5 %-1,614.5 %-379.9 %-588.0 %-372.0 %-234.3 %
ROE-64.0 %-33.9 %-72.4 %-100.6 %495.4 %136.9 %629.1 %
ROI-54.2 %-29.3 %-54.1 %-36.1 %-81.7 %-100.8 %-45.4 %
Login required

This content is only available for logged in users